speb/financial-data huggingface dataset:
Financial ratios for HCG.NS — annual report dated 2023-03-31
Total revenue: 204147015.83434838
Gross profit: 106734713.76370281
Operating income: 20493300.852618758
Net income: 3574786.845310597
Capital expenditures: 15307917.174177833
Operating cash flow: 30644457.97807552
Depreciation & amortization: 19911449.451887943
Net tangible assets: 80461388.55054812
Owner earnings: 8178319.123020709
Return on net tangible assets (%): 10.164277885762383
Capex to operating income (%): 74.69717682020803
Buffett classification: The Good
Stock price: 3.1967113276492083
P/E ratio: 133.5117488750894
Shares outstanding: 149302203
Book value: 105897198.53836787
P/B ratio: 4.506975162333106
Market cap (USD): 477276043.5730816
Debt to equity: 1.0365555729363158
Current ratio: 1.0175603170150092
Quick ratio: 0.9504295833917801
Effective tax rate (%): 60.7174688057041
Interest coverage ratio: 1.7824037290110701
COGS to revenue (%): 47.7167406403281
SG&A to revenue (%): 6.030797465703527
Free cash flow (dilution-adjusted): 13622411.693057247
Buyback yield (%): 0
Retained earnings: -55084652.86236297
Inventory turnover: 20.888967246513083
Receivables turnover: 5.540449768768739
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.63798414043216
FCF margin (%): 6.672843899962231
Rule of 40 score: 6.672843899962231
Financial ratios for HCG.NS — annual report dated 2024-03-31
Total revenue: 226634848.30315384
Gross profit: 117510372.94639646
Operating income: 18879481.952272456
Net income: 5774673.222208898
Capital expenditures: 22062477.515289605
Operating cash flow: 34126274.133589156
Depreciation & amortization: 20908502.218491424
Net tangible assets: 66693008.754047245
Owner earnings: 4620697.925410718
Return on net tangible assets (%): 6.9283092961828805
Capex to operating income (%): 116.8595492771666
Buffett classification: The Gruesome
Stock price: 4.052903071017274
P/E ratio: 104.78642405619655
Shares outstanding: 149302203
Book value: 103743614.34224728
P/B ratio: 5.8327190630944505
Market cap (USD): 605107357.0483445
Debt to equity: 1.4730476073784151
Current ratio: 0.914142032122952
Quick ratio: 0.8567698213673433
Effective tax rate (%): 38.971489317722096
Interest coverage ratio: 1.5635092458339128
COGS to revenue (%): 48.14990994270621
SG&A to revenue (%): 5.714299320390199
Free cash flow (dilution-adjusted): 10918935.124115601
Buyback yield (%): 0
Retained earnings: -59509293.6802974
Inventory turnover: 21.327200712477733
Receivables turnover: 6.427690068225259
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.016934575079961
FCF margin (%): 4.817853567475242
Revenue growth (%): 11.015508787575337
Rule of 40 score: 15.833362355050578
Financial ratios for HCG.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 72849976.11084567
Buffett classification: The Gruesome
Stock price: 5.007166746297181
Shares outstanding: 149302203
Book value: 108164118.49020544
P/B ratio: 6.911543647242008
Market cap (USD): 747581026.0105113
Debt to equity: 1.7204461377063665
Current ratio: 0.9012484588774644
Quick ratio: 0.841889805249991
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCG.NS — quarterly report dated 2025-03-31
Total revenue: 68205517.88636895
Gross profit: 35094692.54150105
Operating income: 5570493.336450783
Net income: 860416.1795651157
Capital expenditures: 0
Depreciation & amortization: 6788636.895019873
Net tangible assets: 49915595.043254614
Owner earnings: 7649053.074584989
Return on net tangible assets (%): 15.323974537329793
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.326292449527367
P/E ratio: 274.439690340929
Shares outstanding: 149302203
Book value: 115741056.81552494
P/B ratio: 8.1607117260226
Market cap (USD): 944529399.5367022
Debt to equity: 1.8556869407473766
Current ratio: 0.8063670540835498
Quick ratio: 0.7556960984998347
Effective tax rate (%): 50.293685756240826
Interest coverage ratio: 1.078786506678741
COGS to revenue (%): 48.54566957475618
Buyback yield (%): 0
Retained earnings: -47841711.48000935
Inventory turnover: 5.341644192143033
Receivables turnover: 1.4553150941890165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9084290484929218
Rule of 40 score: 0
Financial ratios for HCG.NS — annual report dated 2025-03-31
Total revenue: 259310264.2038812
Gross profit: 135126256.7220014
Operating income: 20568155.249006312
Net income: 5708440.4956745375
Capital expenditures: 24237783.49310264
Operating cash flow: 37071545.47580079
Depreciation & amortization: 24706570.02571896
Net tangible assets: 49915595.043254614
Owner earnings: 6177227.02829086
Return on net tangible assets (%): 12.375344865543429
Capex to operating income (%): 117.84130953734227
Buffett classification: The Gruesome
Stock price: 6.326292449527367
P/E ratio: 165.46189808799818
Shares outstanding: 149302203
Book value: 115741056.81552494
P/B ratio: 8.1607117260226
Market cap (USD): 944529399.5367022
Debt to equity: 1.8556869407473766
Current ratio: 0.8063670540835498
Quick ratio: 0.7556960984998347
Effective tax rate (%): 14.27317415730337
Interest coverage ratio: 1.1383281573498965
COGS to revenue (%): 47.89012415807839
SG&A to revenue (%): 4.796225666549452
Free cash flow (dilution-adjusted): 11889174.655132102
Buyback yield (%): 0
Retained earnings: -47841711.48000935
Inventory turnover: 20.034136129604136
Receivables turnover: 5.532956178160919
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.046568872861378
FCF margin (%): 4.584922502637346
Revenue growth (%): 14.417648541419236
Rule of 40 score: 19.00257104405658
Financial ratios for HCG.NS — quarterly report dated 2025-06-30
Total revenue: 71589047.5076059
Gross profit: 37082845.77580155
Operating income: 5836648.7245494975
Net income: 699742.5696232156
Capital expenditures: 0
Depreciation & amortization: 6776269.599812779
Owner earnings: 7476012.169435995
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.442780248069273
P/E ratio: 343.66970305936456
Shares outstanding: 149302203
Market cap (USD): 961921284.4816289
Effective tax rate (%): 49.83221476510067
Interest coverage ratio: 1.0969870244117002
COGS to revenue (%): 48.20039228506048
SG&A to revenue (%): 0.25661981039555415
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.960785763512482
Rule of 40 score: 4.960785763512482
Financial ratios for HCG.NS — quarterly report dated 2025-09-30
Total revenue: 72735062.00676437
Gross profit: 37363021.4205186
Operating income: 6821871.476888387
Net income: 2329199.5490417136
Capital expenditures: 0
Depreciation & amortization: 7080045.095828636
Net tangible assets: 50700112.739571586
Owner earnings: 9409244.644870348
Return on net tangible assets (%): 18.558626670521
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.252536640360766
P/E ratio: 278.4057458107798
Shares outstanding: 149302203
Book value: 112031567.0800451
P/B ratio: 9.665308858622147
Market cap (USD): 1082819697.744081
Debt to equity: 1.7790524493821194
Current ratio: 0.7345354875937681
Quick ratio: 0.6753414118099634
Effective tax rate (%): -4.238143289606458
Interest coverage ratio: 1.3872077028885832
COGS to revenue (%): 48.631347262694526
Buyback yield (%): 0
Inventory turnover: 5.097481722177092
Receivables turnover: 1.4938408817264055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.376855998114541
Revenue growth (%): 1.600823783884979
Rule of 40 score: 1.600823783884979
Financial ratios for HCG.NS — quarterly report dated 2025-12-31
Total revenue: 70310794.25197728
Gross profit: 35144257.54706472
Operating income: 5453937.841149605
Net income: -880026.7349894175
Capital expenditures: 0
Depreciation & amortization: 6756154.617355464
Owner earnings: 5876127.882366046
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.37440124763284
P/E ratio: 365.86674779428216
Shares outstanding: 149302203
Market cap (USD): 1101014352.0775316
Interest coverage ratio: 1.0933452434122377
COGS to revenue (%): 50.01584334104376
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.333011188691405
Rule of 40 score: -3.333011188691405
Financial ratios for HROW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.64
Shares outstanding: 37275107
Market cap (USD): 322056924.48
Buyback yield (%): 3.415545254231324
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HROW — annual report dated 2022-12-31
Total revenue: 88595000
Gross profit: 63212000
Operating income: 1919000
Net income: -14086000
Capital expenditures: 2567000
Operating cash flow: 1705000
Depreciation & amortization: 3665000
Net tangible assets: 1426000
Owner earnings: -12988000
Return on net tangible assets (%): -910.7994389901822
Capex to operating income (%): 133.7675872850443
Buffett classification: The Gruesome
Stock price: 14.76
Shares outstanding: 37275107
Book value: 27240000
P/B ratio: 20.19752493832599
Market cap (USD): 550180579.3199999
Debt to equity: 4.120007342143906
Current ratio: 6.3471446972949765
Quick ratio: 5.9960820094461145
Interest coverage ratio: 0.26490889011595803
COGS to revenue (%): 28.650601049720635
R&D to revenue (%): 3.442632202720244
SG&A to revenue (%): 65.74073028951972
Free cash flow (dilution-adjusted): -14042000
Buyback yield (%): 0
Retained earnings: -109493000
Inventory turnover: 3.8805992967436174
Receivables turnover: 13.868973074514715
Capitalized R&D asset: 3050000
ROCI (R&D-adjusted, %): 2.787337677602565
FCF margin (%): -15.849652914950054
Rule of 40 score: -15.849652914950054
Financial ratios for HROW — annual report dated 2023-12-31
Total revenue: 130193000
Gross profit: 90553000
Operating income: 811000
Net income: -24411000
Capital expenditures: 1460000
Operating cash flow: 3840000
Depreciation & amortization: 12340000
Net tangible assets: -91610000
Owner earnings: -13531000
Capex to operating income (%): 180.02466091245378
Buffett classification: The Gruesome
Stock price: 11.2
Shares outstanding: 37275107
Book value: 70411000
P/B ratio: 5.929204220931388
Market cap (USD): 417481198.4
Debt to equity: 2.744102483986877
Current ratio: 2.826726653696498
Quick ratio: 2.60649724383917
Interest coverage ratio: 0.03803226411555055
COGS to revenue (%): 30.447105451137922
R&D to revenue (%): 5.109337675604679
SG&A to revenue (%): 63.82063551803861
Free cash flow (dilution-adjusted): -164409000
Buyback yield (%): 0
Retained earnings: -133904000
Inventory turnover: 3.6477408668445754
Receivables turnover: 3.568006796568829
Capitalized R&D asset: 8695500
ROCI (R&D-adjusted, %): 1.557553804478934
Rosenberg metric: 8.964262295081967
FCF margin (%): -126.28098284854023
Revenue growth (%): 46.95298831762515
Rule of 40 score: -79.32799453091508
Financial ratios for HROW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.96
Shares outstanding: 37275107
Market cap (USD): 1675888810.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HROW — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.55
Shares outstanding: 37275107
Market cap (USD): 1250579839.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HROW — annual report dated 2024-12-31
Total revenue: 199614000
Gross profit: 150369000
Operating income: 9075000
Net income: -17481000
Capital expenditures: 1595000
Operating cash flow: -22202000
Depreciation & amortization: 14537000
Net tangible assets: -117380000
Owner earnings: -4539000
Capex to operating income (%): 17.575757575757574
Buffett classification: The Great
Stock price: 33.55
Shares outstanding: 37275107
Book value: 69297000
P/B ratio: 18.046666375889288
Market cap (USD): 1250579839.85
Debt to equity: 3.302134291527772
Current ratio: 2.0762510537205916
Quick ratio: 1.9590882716792748
Interest coverage ratio: 0.39827086807688933
COGS to revenue (%): 24.6701133187051
R&D to revenue (%): 6.126824771809593
SG&A to revenue (%): 64.65678760006813
Free cash flow (dilution-adjusted): -78495000
Buyback yield (%): 0
Retained earnings: -151385000
Inventory turnover: 4.601476359558961
Receivables turnover: 1.7119407209200608
Capitalized R&D asset: 17693340
ROCI (R&D-adjusted, %): 4.438118058655127
Rosenberg metric: 8.992182802164763
FCF margin (%): -39.323394150710875
Revenue growth (%): 53.32160715245827
Rule of 40 score: 13.998213001747395
Financial ratios for HROW — quarterly report dated 2025-03-31
Total revenue: 47831000
Gross profit: 32307000
Operating income: -11232000
Net income: -17780000
Capital expenditures: 170000
Operating cash flow: 19668000
Depreciation & amortization: 4908000
Net tangible assets: -126273000
Owner earnings: -13042000
Buffett classification: The Gruesome
Stock price: 26.6
Shares outstanding: 37275107
Book value: 56096000
P/B ratio: 17.67537518183115
Market cap (USD): 991517846.2
Debt to equity: 4.100221049629207
Current ratio: 0.9066721572738066
Quick ratio: 0.8493630539184752
Interest coverage ratio: -1.7153329260843007
COGS to revenue (%): 32.45593861721478
R&D to revenue (%): 6.3264410110597735
SG&A to revenue (%): 84.7002989692877
Free cash flow (dilution-adjusted): 14900000
Buyback yield (%): 0
Retained earnings: -169165000
Inventory turnover: 1.4486748786860768
Receivables turnover: 0.6188430735790713
Capitalized R&D asset: 3026000
ROCI (R&D-adjusted, %): -5.113464000059191
FCF margin (%): 31.151345361794654
Rule of 40 score: 31.151345361794654
Financial ratios for HROW — quarterly report dated 2025-06-30
Total revenue: 63742000
Gross profit: 47512000
Operating income: 11409000
Net income: 4995000
Capital expenditures: 166000
Operating cash flow: -803000
Depreciation & amortization: 4904000
Net tangible assets: -128822000
Owner earnings: 9733000
Return on net tangible assets (%): -7.555386502305507
Capex to operating income (%): 1.4549916732404242
Buffett classification: The Great
Stock price: 30.54
P/E ratio: 56.976064453453446
Shares outstanding: 37275107
Book value: 49299000
P/B ratio: 23.091376453477757
Market cap (USD): 1138381767.78
Debt to equity: 4.690784802937179
Current ratio: 0.6223381173558766
Quick ratio: 0.5759229199144983
Effective tax rate (%): 0
Interest coverage ratio: 1.780430711610487
COGS to revenue (%): 25.462018763138904
R&D to revenue (%): 4.49938815851401
SG&A to revenue (%): 52.13987637664334
Free cash flow (dilution-adjusted): -1971000
Buyback yield (%): 0
Retained earnings: -164170000
Inventory turnover: 1.4049515235457064
Receivables turnover: 0.8063504111321949
Capitalized R&D asset: 4895420
ROCI (R&D-adjusted, %): 12.185070024978454
Rosenberg metric: 5.024785194976867
FCF margin (%): -3.0921527407360925
Revenue growth (%): 33.265037318893604
Rule of 40 score: 30.17288457815751
Financial ratios for HROW — quarterly report dated 2025-09-30
Total revenue: 71638000
Gross profit: 53926000
Operating income: 14747000
Net income: 1020000
Capital expenditures: 210000
Operating cash flow: 16588000
Depreciation & amortization: 4898000
Net tangible assets: -127103000
Owner earnings: 5708000
Return on net tangible assets (%): -4.490846006781901
Capex to operating income (%): 1.4240184444293753
Buffett classification: The Great
Stock price: 48.18
P/E ratio: 440.17516060294116
Shares outstanding: 37275107
Book value: 46661000
P/B ratio: 38.48855908060264
Market cap (USD): 1795914655.26
Debt to equity: 5.397912603673303
Current ratio: 2.71565749235474
Quick ratio: 2.519418960244648
Effective tax rate (%): 0
Interest coverage ratio: 2.442365021530308
COGS to revenue (%): 24.724308327982357
R&D to revenue (%): 4.6385996258968705
SG&A to revenue (%): 50.05164856640331
Free cash flow (dilution-adjusted): 13092000
Buyback yield (%): 0
Retained earnings: -163150000
Inventory turnover: 1.3800841514726507
Receivables turnover: 0.9204656421853318
Capitalized R&D asset: 6243140
ROCI (R&D-adjusted, %): 4.93478803685329
Rosenberg metric: 2.2364016736401675
FCF margin (%): 18.275217063569613
Revenue growth (%): 12.387436854820997
Rule of 40 score: 30.66265391839061
Financial ratios for HROW — annual report dated 2025-12-31
Total revenue: 272303000
Gross profit: 204369000
Operating income: 30515000
Net income: -5139000
Capital expenditures: 887000
Operating cash flow: 43864000
Depreciation & amortization: 19677000
Net tangible assets: -124243000
Owner earnings: 13651000
Capex to operating income (%): 2.9067671636899886
Buffett classification: The Great
Stock price: 49
Shares outstanding: 37275107
Book value: 52091000
P/B ratio: 35.06325935382312
Market cap (USD): 1826480243
Debt to equity: 4.8372271601620245
Current ratio: 2.1988120703619862
Quick ratio: 2.0583892338684553
Interest coverage ratio: 1.261993382961125
COGS to revenue (%): 24.947944018244385
R&D to revenue (%): 7.689963019136771
SG&A to revenue (%): 56.155826413957975
Free cash flow (dilution-adjusted): 30260000
Buyback yield (%): 0
Retained earnings: -156524000
Inventory turnover: 5.02358944021297
Receivables turnover: 2.4555029532440598
Capitalized R&D asset: 31329260
ROCI (R&D-adjusted, %): 11.414033799841594
Rosenberg metric: 4.415372035977105
FCF margin (%): 11.112620867195734
Revenue growth (%): 36.41478052641599
Rule of 40 score: 47.527401393611726
Financial ratios for HROW — quarterly report dated 2025-12-31
Total revenue: 89092000
Gross profit: 70624000
Operating income: 15591000
Net income: 6626000
Capital expenditures: 341000
Operating cash flow: 8411000
Depreciation & amortization: 4967000
Net tangible assets: -124243000
Owner earnings: 11252000
Return on net tangible assets (%): -9.05644583598271
Capex to operating income (%): 2.1871592585465973
Buffett classification: The Great
Stock price: 49
P/E ratio: 68.9133807349834
Shares outstanding: 37275107
Book value: 52091000
P/B ratio: 35.06325935382312
Market cap (USD): 1826480243
Debt to equity: 4.8372271601620245
Current ratio: 2.1988120703619862
Quick ratio: 2.0583892338684553
Effective tax rate (%): 36.270077907088584
Interest coverage ratio: 3.006363285769379
COGS to revenue (%): 20.7291339289723
R&D to revenue (%): 13.158308265613075
SG&A to revenue (%): 48.61267004893818
Free cash flow (dilution-adjusted): 4239000
Buyback yield (%): 0
Retained earnings: -156524000
Inventory turnover: 1.3656732973452637
Receivables turnover: 0.8033905947067045
Capitalized R&D asset: 14895850
ROCI (R&D-adjusted, %): 6.709929932331131
Rosenberg metric: 5.024977430033102
FCF margin (%): 4.758002963229021
Revenue growth (%): 24.364164270359307
Rule of 40 score: 29.12216723358833
Financial ratios for HT8.AX — annual report dated 2021-06-30
Total revenue: 31429218.79699248
Gross profit: 5768754.135338346
Operating income: 860378.947368421
Net income: 1318357.894736842
Capital expenditures: 10732.330827067668
Depreciation & amortization: 54521.80451127819
Net tangible assets: 5760235.338345865
Owner earnings: 1362147.3684210526
Return on net tangible assets (%): 23.647425641678957
Capex to operating income (%): 1.2473957969210978
Buffett classification: The Great
Stock price: 0.09022556390977443
P/E ratio: 25.58449205436702
Shares outstanding: 373835481
Book value: 5760235.338345864
P/B ratio: 5.855579694490866
Market cap (USD): 33729517.082706764
Debt to equity: 0.3194015021055035
Current ratio: 1.6525671173211394
Quick ratio: 0.6248336116614301
Effective tax rate (%): -55.78386984427086
Interest coverage ratio: 16.930579392791618
COGS to revenue (%): 81.64525127843658
SG&A to revenue (%): 6.457931572270724
Free cash flow (dilution-adjusted): -3039121.052631579
Buyback yield (%): 1.4444856827273707
Retained earnings: -7484612.781954886
Inventory turnover: 3.1697863838314637
Receivables turnover: 13.15443078048225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.668790683382765
FCF margin (%): -9.669731444048486
Rule of 40 score: -9.669731444048486
Financial ratios for HT8.AX — annual report dated 2022-06-30
Total revenue: 34686616.551724136
Gross profit: 5143525.517241379
Operating income: -925913.7931034483
Net income: -1010164.1379310346
Capital expenditures: 77257.24137931035
Depreciation & amortization: 100111.03448275862
Net tangible assets: 4335364.137931035
Owner earnings: -987310.3448275863
Return on net tangible assets (%): -22.773412184443643
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 373835481
Book value: 3708544.8275862066
P/B ratio: 2.0855962520851197
Market cap (USD): 7734527.1931034485
Debt to equity: 0.8723083131407616
Current ratio: 1.4307507246899
Quick ratio: 0.48776069110883613
Interest coverage ratio: -9.994379638659153
COGS to revenue (%): 85.17144066337103
SG&A to revenue (%): 7.431708630382216
Free cash flow (dilution-adjusted): -1060746.2068965517
Buyback yield (%): 0
Retained earnings: -7796211.0344827585
Inventory turnover: 4.376443013605367
Receivables turnover: 20.604284427941362
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.34771647011878
FCF margin (%): -3.0580849686356224
Revenue growth (%): 10.364233918036046
Rule of 40 score: 7.3061489494004235
Financial ratios for HT8.AX — annual report dated 2023-06-30
Total revenue: 16016923.841059603
Gross profit: 2488505.9602649007
Operating income: -1558683.4437086093
Net income: -2187862.913907285
Capital expenditures: 15202.649006622516
Depreciation & amortization: 112695.36423841059
Net tangible assets: 1969062.9139072848
Owner earnings: -2090370.198675497
Return on net tangible assets (%): -106.16066068338557
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 373835481
Book value: 698208.6092715226
P/B ratio: 3.5458337656917687
Market cap (USD): 2475731.6622516555
Debt to equity: 5.296598200693358
Current ratio: 2.531318113001606
Quick ratio: 1.6445571046331504
Interest coverage ratio: -13.938162157040408
COGS to revenue (%): 84.46327156850442
SG&A to revenue (%): 10.788873771968435
Free cash flow (dilution-adjusted): 299082.7814569536
Buyback yield (%): 0
Retained earnings: -9674290.72847682
Inventory turnover: 4.3025557857179715
Receivables turnover: 16.217440137327085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -53.80499947763513
FCF margin (%): 1.867292274252131
Revenue growth (%): -53.82390837349207
Rule of 40 score: -51.95661609923994
Financial ratios for HT8.AX — annual report dated 2024-06-30
Total revenue: 11139094
Gross profit: 3243284
Operating income: -823552.6666666666
Net income: -937862.6666666666
Capital expenditures: 3881.3333333333335
Depreciation & amortization: 111428.66666666667
Net tangible assets: 1044213.3333333334
Owner earnings: -830315.3333333334
Return on net tangible assets (%): -79.51587159711936
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 373835481
Book value: 1050540.666666667
P/B ratio: 2.37233704422675
Market cap (USD): 2492236.54
Debt to equity: 2.0037466422051877
Current ratio: 2.028231113563246
Quick ratio: 0.9079661873964436
Interest coverage ratio: -6.6572663436821315
COGS to revenue (%): 70.88377205542929
SG&A to revenue (%): 32.12299552070094
Free cash flow (dilution-adjusted): 5237.333333333333
Buyback yield (%): 0
Retained earnings: -10676648.666666666
Inventory turnover: 3.609547244484443
Receivables turnover: 14.149864417860597
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.19096011779085
FCF margin (%): 0.04701758808511117
Revenue growth (%): -30.45422385386649
Rule of 40 score: -30.40720626578138
Financial ratios for ICFI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 100.06
Shares outstanding: 18104180
Market cap (USD): 1811504250.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICFI — annual report dated 2022-12-31
Total revenue: 1779964000
Gross profit: 645542000
Operating income: 108762000
Net income: 64243000
Capital expenditures: 24475000
Operating cash flow: 162206000
Depreciation & amortization: 49917000
Net tangible assets: -486224000
Owner earnings: 89685000
Return on net tangible assets (%): -18.445202211326468
Capex to operating income (%): 22.503264007649733
Buffett classification: The Great
Stock price: 97.19
P/E ratio: 27.388902358233583
Shares outstanding: 18104180
Book value: 853211000
P/B ratio: 2.06226273946304
Market cap (USD): 1759545254.2
Debt to equity: 0.9099589667737523
Current ratio: 1.1219398449970193
Quick ratio: 1.1219398449970193
Effective tax rate (%): 23.502024291497975
Interest coverage ratio: 4.671706541815214
COGS to revenue (%): 63.732862012939584
SG&A to revenue (%): 27.35240712733516
Free cash flow (dilution-adjusted): 124560000
Buyback yield (%): 1.2058797549737952
Retained earnings: 703030000
Receivables turnover: 4.309412382790086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.488349701061765
FCF margin (%): 6.997894339436078
Rule of 40 score: 6.997894339436078
Financial ratios for ICFI — annual report dated 2023-12-31
Total revenue: 1963238000
Gross profit: 698220000
Operating income: 132320000
Net income: 82612000
Capital expenditures: 22337000
Operating cash flow: 152383000
Depreciation & amortization: 60738000
Net tangible assets: -396795000
Owner earnings: 121013000
Return on net tangible assets (%): -30.497612117088167
Capex to operating income (%): 16.881045949214027
Buffett classification: The Great
Stock price: 132.17
P/E ratio: 28.964671846705077
Shares outstanding: 18104180
Book value: 917585000
P/B ratio: 2.6077469341804846
Market cap (USD): 2392829470.6
Debt to equity: 0.7003950587683975
Current ratio: 1.0691755175431465
Quick ratio: 1.0691755175431465
Effective tax rate (%): 14.433384776326555
Interest coverage ratio: 3.3345933822232303
COGS to revenue (%): 64.43528497309038
SG&A to revenue (%): 25.73106266280502
Free cash flow (dilution-adjusted): 115185000
Buyback yield (%): 0.7975077302610686
Retained earnings: 775099000
Receivables turnover: 4.7924414077280035
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.303494219809156
FCF margin (%): 5.867093037115215
Revenue growth (%): 10.296500378659344
Rule of 40 score: 16.163593415774557
Financial ratios for ICFI — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 13110000
Buffett classification: The Gruesome
Stock price: 164.85
Shares outstanding: 18104180
Market cap (USD): 2984474073
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICFI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 117.95
Shares outstanding: 18104180
Market cap (USD): 2135388031
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICFI — annual report dated 2024-12-31
Total revenue: 2019787000
Gross profit: 737771000
Operating income: 165842000
Net income: 110170000
Capital expenditures: 21430000
Operating cash flow: 171544000
Depreciation & amortization: 53476000
Net tangible assets: -378097000
Owner earnings: 142216000
Return on net tangible assets (%): -37.61362824883562
Capex to operating income (%): 12.921937747976992
Buffett classification: The Great
Stock price: 117.95
P/E ratio: 19.38266343832259
Shares outstanding: 18104180
Book value: 982459000
P/B ratio: 2.1735136336478162
Market cap (USD): 2135388031
Debt to equity: 0.6130250728020202
Current ratio: 1.0954940113094973
Quick ratio: 1.0954940113094973
Effective tax rate (%): 20.200205710643353
Interest coverage ratio: 5.60466373774924
COGS to revenue (%): 63.472831541147656
SG&A to revenue (%): 25.668696748716574
Free cash flow (dilution-adjusted): 133392000
Buyback yield (%): 2.2369236553990968
Retained earnings: 874772000
Receivables turnover: 4.467329759092638
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.255056199924189
FCF margin (%): 6.604260746306418
Revenue growth (%): 2.8803945318906825
Rule of 40 score: 9.4846552781971
Financial ratios for ICFI — quarterly report dated 2025-03-31
Total revenue: 487618000
Gross profit: 185076000
Operating income: 38390000
Net income: 26851000
Capital expenditures: 3452000
Operating cash flow: -33034000
Depreciation & amortization: 14795000
Net tangible assets: -384948000
Owner earnings: 38194000
Return on net tangible assets (%): -9.921859575838814
Capex to operating income (%): 8.991924980463663
Buffett classification: The Great
Stock price: 84.21
P/E ratio: 14.194564427768052
Shares outstanding: 18104180
Book value: 968868000
P/B ratio: 1.5735404593814637
Market cap (USD): 1524552997.8
Debt to equity: 0.7092730898326707
Current ratio: 1.3389065518298835
Quick ratio: 1.3389065518298835
Effective tax rate (%): 10.499650011666278
Interest coverage ratio: 5.232383808095952
COGS to revenue (%): 62.044879393295574
SG&A to revenue (%): 27.04801709534923
Free cash flow (dilution-adjusted): -40672000
Buyback yield (%): 2.5805596825280794
Retained earnings: 899051000
Receivables turnover: 1.047406497289216
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2668078279564305
FCF margin (%): -8.34095542002141
Rule of 40 score: -8.34095542002141
Financial ratios for ICFI — quarterly report dated 2025-06-30
Total revenue: 476155000
Gross profit: 177730000
Operating income: 40011000
Net income: 23661000
Capital expenditures: 5750000
Operating cash flow: 51957000
Depreciation & amortization: 14702000
Net tangible assets: -348251000
Owner earnings: 32613000
Return on net tangible assets (%): -9.36479722958441
Capex to operating income (%): 14.3710479618105
Buffett classification: The Great
Stock price: 84.09
P/E ratio: 30.138986700190056
Shares outstanding: 18104180
Book value: 1000392000
P/B ratio: 1.5217839568888998
Market cap (USD): 1522380496.2
Debt to equity: 0.6439835584450895
Current ratio: 1.2864784916861287
Quick ratio: 1.2864784916861287
Effective tax rate (%): 20.998330550918197
Interest coverage ratio: 4.7507717881738305
COGS to revenue (%): 62.67391920698092
SG&A to revenue (%): 25.835494744358456
Free cash flow (dilution-adjusted): 41955000
Buyback yield (%): 0.0019049114247316381
Retained earnings: 920135000
Receivables turnover: 1.041477103711351
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3809098763933423
FCF margin (%): 8.811206434879399
Revenue growth (%): -2.350815597455385
Rule of 40 score: 6.460390837424013
Financial ratios for ICFI — quarterly report dated 2025-09-30
Total revenue: 465405000
Gross profit: 174860000
Operating income: 38431000
Net income: 23766000
Capital expenditures: 5543000
Operating cash flow: 47321000
Depreciation & amortization: 14168000
Net tangible assets: -316839000
Owner earnings: 32391000
Return on net tangible assets (%): -10.223173283591983
Capex to operating income (%): 14.423252062137337
Buffett classification: The Great
Stock price: 92.26
P/E ratio: 22.48703043700692
Shares outstanding: 18104180
Book value: 1024121000
P/B ratio: 1.6309514664771059
Market cap (USD): 1670291646.8000002
Debt to equity: 0.6092522270317667
Current ratio: 1.4105484970560893
Quick ratio: 1.4105484970560893
Effective tax rate (%): 22.70214011578742
Interest coverage ratio: 4.888818216511894
COGS to revenue (%): 62.428422556697925
SG&A to revenue (%): 26.26980801667365
Free cash flow (dilution-adjusted): 37301000
Buyback yield (%): 0.011914087002784858
Retained earnings: 941319000
Receivables turnover: 0.9384830373130717
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2471706442832544
FCF margin (%): 8.014739850237964
Revenue growth (%): -2.2576681962806227
Rule of 40 score: 5.757071653957341
Financial ratios for ICFI — quarterly report dated 2025-12-31
Total revenue: 443673000
Gross profit: 158350000
Operating income: 28633000
Net income: 17310000
Capital expenditures: 6914000
Operating cash flow: 75626000
Depreciation & amortization: 14482000
Net tangible assets: -305280000
Owner earnings: 24878000
Return on net tangible assets (%): -8.14924004192872
Capex to operating income (%): 24.146963294101212
Buffett classification: The Great
Stock price: 84.95
P/E ratio: 16.792047986635804
Shares outstanding: 18104180
Book value: 1028482000
P/B ratio: 1.4953592683197179
Market cap (USD): 1537950091
Debt to equity: 0.5555167713192841
Current ratio: 1.2724889123051768
Quick ratio: 1.2724889123051768
Effective tax rate (%): 18.717129977460555
Interest coverage ratio: 3.9696381533342575
COGS to revenue (%): 64.30929986724458
SG&A to revenue (%): 25.972957561086655
Free cash flow (dilution-adjusted): 63941000
Buyback yield (%): 1.0256509682796984
Retained earnings: 956077000
Receivables turnover: 1.0020462229569955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7396624569990533
FCF margin (%): 14.411740178013988
Revenue growth (%): -4.669481419408902
Rule of 40 score: 9.742258758605086
Financial ratios for ICFI — annual report dated 2025-12-31
Total revenue: 1872851000
Gross profit: 696016000
Operating income: 145465000
Net income: 91588000
Capital expenditures: 21659000
Operating cash flow: 141870000
Depreciation & amortization: 58147000
Net tangible assets: -305280000
Owner earnings: 128076000
Return on net tangible assets (%): -41.95361635220126
Capex to operating income (%): 14.889492317739665
Buffett classification: The Great
Stock price: 84.95
P/E ratio: 16.792047986635804
Shares outstanding: 18104180
Book value: 1028482000
P/B ratio: 1.4953592683197179
Market cap (USD): 1537950091
Debt to equity: 0.5555167713192841
Current ratio: 1.2724889123051768
Quick ratio: 1.2724889123051768
Effective tax rate (%): 18.21988874304644
Interest coverage ratio: 4.717834787403107
COGS to revenue (%): 62.836552400591394
SG&A to revenue (%): 26.291680438006015
Free cash flow (dilution-adjusted): 102525000
Buyback yield (%): 3.594785053398719
Retained earnings: 956077000
Receivables turnover: 4.229879372220603
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.838053969453682
FCF margin (%): 5.47427424819166
Revenue growth (%): -7.274826503982846
Rule of 40 score: -1.8005522557911853
Financial ratios for IDEX.V — quarterly report dated 2025-07-31
Total revenue: 0
Operating income: -959713.043478261
Net income: -1580186.231884058
Capital expenditures: 34905.79710144928
Operating cash flow: 1297275.3623188406
Net tangible assets: 2327074.6376811597
Owner earnings: -1615092.0289855073
Return on net tangible assets (%): -69.40439308791936
Buffett classification: The Gruesome
Stock price: 0.33333333333333337
Shares outstanding: 77533899
Book value: 2327074.6376811597
P/B ratio: 11.1060610525811
Market cap (USD): 25844633.000000004
Debt to equity: 0.042366745833466966
Current ratio: 4.438506380914495
Quick ratio: 4.438506380914495
Interest coverage ratio: -282.690288153682
Free cash flow (dilution-adjusted): 1177365.2173913044
Buyback yield (%): 0
Retained earnings: -4630840.5797101455
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -39.888647039849076
Rule of 40 score: 0
Financial ratios for IDEX.V — annual report dated 2025-07-31
Total revenue: 0
Gross profit: -2544.9275362318845
Operating income: -2183457.971014493
Net income: -2756626.086956522
Capital expenditures: 367116.6666666667
Operating cash flow: -2154997.8260869565
Depreciation & amortization: 2544.9275362318845
Net tangible assets: 2327074.6376811597
Owner earnings: -3121197.8260869565
Return on net tangible assets (%): -134.12538538931912
Buffett classification: The Gruesome
Stock price: 0.33333333333333337
Shares outstanding: 77533899
Book value: 2327074.6376811597
P/B ratio: 11.1060610525811
Market cap (USD): 25844633.000000004
Debt to equity: 0.042366745833466966
Current ratio: 4.438506380914495
Quick ratio: 4.438506380914495
Interest coverage ratio: -151.11951451928383
Free cash flow (dilution-adjusted): -2969437.681159421
Buyback yield (%): 0
Retained earnings: -4630840.5797101455
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -90.7512770864148
Rule of 40 score: 0
Financial ratios for IDEX.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: -6891.428571428572
Operating income: -2136269.285714286
Net income: -2178969.285714286
Capital expenditures: 159048.57142857145
Operating cash flow: -1044098.5714285715
Depreciation & amortization: 6891.428571428572
Net tangible assets: 4060798.571428572
Owner earnings: -2331126.4285714286
Return on net tangible assets (%): -57.40561585529095
Buffett classification: The Gruesome
Stock price: 0.3785714285714286
Shares outstanding: 77533899
Book value: 4060798.5714285714
P/B ratio: 7.228164212246783
Market cap (USD): 29352118.90714286
Debt to equity: 0.023067770976785355
Current ratio: 4.371129121759451
Quick ratio: 4.371129121759451
Interest coverage ratio: -762.3698699974509
Free cash flow (dilution-adjusted): -1417268.5714285716
Buyback yield (%): 0
Retained earnings: -6743659.285714286
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -51.67545669926962
Rule of 40 score: 0
Financial ratios for IDEX.V — quarterly report dated 2026-01-31
Total revenue: 0
Gross profit: -7145.185185185184
Operating income: -1344205.9259259258
Net income: -1349173.3333333333
Capital expenditures: 59.25925925925925
Operating cash flow: -1901161.4814814813
Depreciation & amortization: 7145.185185185184
Net tangible assets: 2992917.037037037
Owner earnings: -1342087.4074074074
Return on net tangible assets (%): -44.84211860199315
Buffett classification: The Gruesome
Stock price: 0.3259259259259259
Shares outstanding: 77533899
Book value: 2992917.037037037
P/B ratio: 8.443370634569815
Market cap (USD): 25270307.82222222
Debt to equity: 0.029933140911950634
Current ratio: 6.1155680060813635
Quick ratio: 6.1155680060813635
Interest coverage ratio: -486.7698497854077
Free cash flow (dilution-adjusted): -2073479.259259259
Buyback yield (%): 0
Retained earnings: -8342593.333333333
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.91367097282532
Rule of 40 score: 0
Financial ratios for IMC.AX — annual report dated 2021-06-30
Capital expenditures: 4984.962406015037
Buffett classification: The Gruesome
Stock price: 0.12030075187969924
Shares outstanding: 322848081
Market cap (USD): 38838866.88721804
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMC.AX — annual report dated 2022-06-30
Total revenue: 527719.3103448276
Gross profit: 361035.8620689655
Operating income: -2149940
Net income: -1968451.0344827587
Capital expenditures: 6929.6551724137935
Depreciation & amortization: 29383.44827586207
Net tangible assets: 15984414.48275862
Owner earnings: -1945997.2413793104
Return on net tangible assets (%): -12.17434172192128
Buffett classification: The Gruesome
Stock price: 0.055172413793103454
Shares outstanding: 322848081
Book value: 15984414.482758623
P/B ratio: 1.1143547320081315
Market cap (USD): 17812307.91724138
Debt to equity: 0.00905135998639364
Current ratio: 15.750186297053311
Quick ratio: 15.532898728921818
Interest coverage ratio: -504.10947606727035
COGS to revenue (%): 31.585626110014076
R&D to revenue (%): 85.95413183340675
SG&A to revenue (%): 508.3044408404154
Free cash flow (dilution-adjusted): -2177821.379310345
Buyback yield (%): 0
Retained earnings: -47189848.965517245
Inventory turnover: 0.7400712846548145
Receivables turnover: 1.15431832444305
Capitalized R&D asset: 453596.551724138
ROCI (R&D-adjusted, %): -11.15732410495053
FCF margin (%): -412.6855577612446
Rule of 40 score: -412.6855577612446
Financial ratios for IMC.AX — annual report dated 2023-06-30
Total revenue: 1195168.8741721853
Gross profit: 866984.7682119205
Operating income: -2255973.509933775
Net income: -2507620.5298013245
Capital expenditures: 5125.165562913908
Depreciation & amortization: 32226.490066225164
Net tangible assets: 12991282.119205298
Owner earnings: -2480519.205298013
Return on net tangible assets (%): -19.093721332023165
Buffett classification: The Gruesome
Stock price: 0.052980132450331126
Shares outstanding: 322848081
Book value: 12991282.119205298
P/B ratio: 1.3166163228361598
Market cap (USD): 17104534.092715234
Debt to equity: 0.009639271083267455
Current ratio: 9.196961974892064
Quick ratio: 8.818451210131498
Interest coverage ratio: -352.9341069208454
COGS to revenue (%): 27.4592246378217
R&D to revenue (%): 143.6326158568852
SG&A to revenue (%): 281.3855450059705
Free cash flow (dilution-adjusted): -1723797.3509933774
Buyback yield (%): 0
Retained earnings: -47718805.29801325
Inventory turnover: 0.5899724751419102
Receivables turnover: 4.323475156916295
Capitalized R&D asset: 2020562.007535967
ROCI (R&D-adjusted, %): -8.355503687282525
Rosenberg metric: 1.1154161208232816
FCF margin (%): -144.23044209441434
Revenue growth (%): 126.4781391818363
Rule of 40 score: -17.752302912578045
Financial ratios for IMC.AX — annual report dated 2024-06-30
Total revenue: 3268576.6666666665
Gross profit: 2224531.3333333335
Operating income: -3477226
Net income: -4624638
Capital expenditures: 130
Depreciation & amortization: 30654
Net tangible assets: 8472962.666666666
Owner earnings: -4594114
Return on net tangible assets (%): -54.22086914266273
Buffett classification: The Gruesome
Stock price: 0.06
Shares outstanding: 322848081
Book value: 8472962.666666666
P/B ratio: 2.2861997180993914
Market cap (USD): 19370884.86
Debt to equity: 0.010460016976352389
Current ratio: 5.456262164322139
Quick ratio: 4.869148296448397
Interest coverage ratio: -688.4687170010559
COGS to revenue (%): 31.94189519801178
R&D to revenue (%): 109.63918035679139
SG&A to revenue (%): 133.6173849371745
Free cash flow (dilution-adjusted): -3920222.6666666665
Buyback yield (%): 0
Retained earnings: -52645597.333333336
Inventory turnover: 0.9882999454754742
Receivables turnover: 3.533410494438851
Capitalized R&D asset: 4883484.581715764
ROCI (R&D-adjusted, %): -13.467949840634235
Rosenberg metric: 0.7908104343442722
FCF margin (%): -119.93669007814817
Revenue growth (%): 173.48241217632062
Rule of 40 score: 53.54572209817245
Financial ratios for IMC.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 6422059.627329192
Buffett classification: The Gruesome
Stock price: 0.049689440993788817
Shares outstanding: 322848081
Book value: 6422059.627329192
P/B ratio: 2.4979744196923725
Market cap (USD): 16042140.670807453
Debt to equity: 0
Current ratio: 6.7999890092727036
Quick ratio: 5.922604455293771
Buyback yield (%): 0
Retained earnings: -49998352.795031056
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMC.AX — annual report dated 2025-06-30
Total revenue: 4762746.405228758
Gross profit: 3114443.790849673
Operating income: -3501131.3725490198
Net income: -3409141.8300653594
Capital expenditures: 0
Depreciation & amortization: 32475.81699346405
Net tangible assets: 5273892.156862745
Owner earnings: -3376666.013071895
Return on net tangible assets (%): -64.026072445906
Buffett classification: The Gruesome
Stock price: 0.0392156862745098
Shares outstanding: 322848081
Book value: 5273892.156862745
P/B ratio: 2.400638595225835
Market cap (USD): 12660709.05882353
Debt to equity: 0.008905008083350529
Current ratio: 5.093670564181853
Quick ratio: 4.192259728106357
Interest coverage ratio: -733.2965092402466
COGS to revenue (%): 34.60823806553093
R&D to revenue (%): 49.36592579499773
SG&A to revenue (%): 107.96096940826968
Free cash flow (dilution-adjusted): -4011077.7777777775
Buyback yield (%): 0
Retained earnings: -53884447.7124183
Inventory turnover: 1.4229043373169041
Receivables turnover: 3.7842898265625187
Capitalized R&D asset: 5318708.36777648
ROCI (R&D-adjusted, %): -34.731576249780765
Rosenberg metric: 0.24832636424569157
FCF margin (%): -84.21774825916062
Revenue growth (%): 45.713161750183566
Rule of 40 score: -38.50458650897705
Financial ratios for IMC.AX — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 5273892.156862745
Buffett classification: The Gruesome
Stock price: 0.0392156862745098
Shares outstanding: 322848081
Book value: 5273892.156862745
P/B ratio: 2.400638595225835
Market cap (USD): 12660709.05882353
Debt to equity: 0.008905008083350529
Current ratio: 5.093670564181853
Quick ratio: 4.192259728106357
Buyback yield (%): 0
Retained earnings: -53884447.7124183
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMDA.PA — annual report dated 2021-12-31
Capital expenditures: 651136.3636363636
Buffett classification: The Gruesome
Stock price: 62.14772727272727
Shares outstanding: 7537249
Market cap (USD): 468422895.2386364
Buyback yield (%): 0
Retained earnings: 539640909.0909091
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMDA.PA — annual report dated 2022-12-31
Total revenue: 27315957.446808513
Gross profit: 24629787.234042555
Operating income: 23026595.74468085
Net income: 47182978.72340426
Capital expenditures: 0
Operating cash flow: 16794680.85106383
Depreciation & amortization: 88297.87234042554
Net tangible assets: 661601063.8297873
Owner earnings: 47271276.595744684
Return on net tangible assets (%): 7.144981950619468
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 50.9468085106383
P/E ratio: 8.138502313537156
Shares outstanding: 7537249
Book value: 665889361.7021277
P/B ratio: 0.576670545566959
Market cap (USD): 383998781.5
Debt to equity: 0.3897315380486184
Current ratio: 0.33773133799698934
Quick ratio: 0.33773133799698934
Effective tax rate (%): 0.027049568333972002
Interest coverage ratio: 5.495049504950495
COGS to revenue (%): 9.833703314250107
Free cash flow (dilution-adjusted): 16784042.55319149
Buyback yield (%): 0.012743834764685564
Retained earnings: 542505319.1489362
Receivables turnover: 1.8749178532311064
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5940702514252707
FCF margin (%): 61.4440939362075
Rule of 40 score: 61.4440939362075
Financial ratios for IMDA.PA — annual report dated 2023-12-31
Total revenue: 30711111.111111112
Gross profit: 27984444.444444444
Operating income: 31073333.333333332
Net income: -28773333.333333332
Capital expenditures: 102222.22222222222
Operating cash flow: 14606666.666666666
Depreciation & amortization: 84444.44444444444
Net tangible assets: 648224444.4444444
Owner earnings: -28791111.111111112
Return on net tangible assets (%): -4.44153431081827
Capex to operating income (%): 0.3289708932274905
Buffett classification: The Great
Stock price: 49.33333333333333
Shares outstanding: 7537249
Book value: 652947777.7777777
P/B ratio: 0.569475278097789
Market cap (USD): 371837617.3333333
Debt to equity: 0.429418381255605
Current ratio: 0.13491209436229978
Quick ratio: 0.13491209436229978
Interest coverage ratio: 4.96908315565032
COGS to revenue (%): 8.878437047756874
Free cash flow (dilution-adjusted): 14496666.666666666
Buyback yield (%): 0.013745546100918733
Receivables turnover: 1.6832105231106511
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9176901234031765
FCF margin (%): 47.20332850940665
Revenue growth (%): 12.429195172506299
Rule of 40 score: 59.63252368191295
Financial ratios for IMDA.PA — annual report dated 2024-12-31
Total revenue: 31015625
Gross profit: 28789583.333333336
Operating income: 27883333.333333336
Net income: 28437500
Capital expenditures: 0
Operating cash flow: 21730208.333333336
Depreciation & amortization: 223958.33333333334
Net tangible assets: 621815625
Owner earnings: 28661458.333333332
Return on net tangible assets (%): 4.609317807562866
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 49.625
P/E ratio: 13.152913639560438
Shares outstanding: 7537249
Book value: 625877083.3333334
P/B ratio: 0.5976189120600757
Market cap (USD): 374035981.625
Debt to equity: 0.43695014662756604
Current ratio: 0.09809137574090356
Quick ratio: 0.09809137574090356
Effective tax rate (%): 0.05932517612161662
Interest coverage ratio: 3.0550102716274825
COGS to revenue (%): 7.177162048698574
Free cash flow (dilution-adjusted): 21730208.333333336
Buyback yield (%): 0
Receivables turnover: 1.8719351188230857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7914530834592757
FCF margin (%): 70.0621326616289
Revenue growth (%): 0.9915430535455834
Rule of 40 score: 71.05367571517448
Financial ratios for IMDA.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 621815625
Buffett classification: The Gruesome
Stock price: 49.625
Shares outstanding: 7537249
Book value: 625877083.3333334
P/B ratio: 0.5976189120600757
Market cap (USD): 374035981.625
Debt to equity: 0.43695014662756604
Current ratio: 0.09809137574090356
Quick ratio: 0.09809137574090356
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0